BlackRock’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-9,368,042
| Closed | -$37.5M | – | 5158 |
|
|
2019
Q4 | $37.5M | Buy |
9,368,042
+64,684
| +0.7% | +$304K | ﹤0.01% | 2536 |
|
|
2019
Q3 | $45.6M | Buy |
9,303,358
+149,109
| +2% | +$834K | ﹤0.01% | 2348 |
|
|
2019
Q2 | $55.7M | Buy |
9,154,249
+614,918
| +7% | +$3.27M | ﹤0.01% | 2259 |
|
|
2019
Q1 | $49.6M | Sell |
8,539,331
-111,120
| -1% | -$1.15M | ﹤0.01% | 2284 |
|
|
2018
Q4 | $116M | Buy |
8,650,451
+186,200
| +2% | +$3.14M | 0.01% | 1689 |
|
|
2018
Q3 | $164M | Buy |
8,464,251
+1,228,490
| +17% | +$26.2M | 0.01% | 1623 |
|
|
2018
Q2 | $185M | Buy |
7,235,761
+724,925
| +11% | +$16.9M | 0.01% | 1525 |
|
|
2018
Q1 | $131M | Sell |
6,510,836
-243,874
| -4% | -$5.69M | 0.01% | 1654 |
|
|
2017
Q4 | $136M | Buy |
6,754,710
+237,500
| +4% | +$4.67M | 0.01% | 1656 |
|
|
2017
Q3 | $135M | Buy |
6,517,210
+842,696
| +15% | +$14.2M | 0.01% | 1643 |
|
|
2017
Q2 | $84M | Buy |
5,674,514
+125,897
| +2% | +$2.1M | ﹤0.01% | 1922 |
|
|
2017
Q1 | $88.5M | Buy |
5,548,617
+5,545,129
| +158,977% | +$80M | ﹤0.01% | 1860 |
|
|
2016
Q4 | $44K | Sell |
3,488
-428
| -11% | -$7.97K | ﹤0.01% | 2998 |
|
|
2016
Q3 | $109K | Sell |
3,916
-2,996
| -43% | -$101K | ﹤0.01% | 2534 |
|
|
2016
Q2 | $242K | Buy |
6,912
+4,405
| +176% | +$138K | ﹤0.01% | 1993 |
|
|
2016
Q1 | $68K | Buy |
2,507
+1,357
| +118% | +$40K | ﹤0.01% | 2206 |
|
|
2015
Q4 | $39K | Buy |
1,150
+305
| +36% | +$9.52K | ﹤0.01% | 2204 |
|
|
2015
Q3 | $25K | Sell |
845
-182
| -18% | -$7.78K | ﹤0.01% | 2262 |
|
|
2015
Q2 | $46K | Sell |
1,027
-76
| -7% | -$2.86K | ﹤0.01% | 2011 |
|
|
2015
Q1 | $38K | Sell |
1,103
-331
| -23% | -$9.01K | ﹤0.01% | 2069 |
|
|
2014
Q4 | $39K | Buy |
+1,434
| New | +$34.8K | ﹤0.01% | 2076 |
|
Other funds holding DPLO
BlackRock's DPLO Position: Q1 2020 in Review
BlackRock sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 9,368,042 shares — an estimated $37.5M sold.
BlackRock first reported a position in DPLO in Q4 2014 and held it in 21 quarters. The position peaked at $185M in Q2 2018. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.
- BlackRock reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
- BlackRock sold 9,368,042 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $37.5M.
- BlackRock first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2014 and held it in 21 quarters.
- BlackRock's DIPLOMAT PHARMACY, INC. position peaked at $185M in Q2 2018.
- 1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.
Based on BlackRock's 13F filing for Q1 2020, filed 1 May 2020.